Skip to content

Randomized controlled study of different pharmaceutical care modes for patients with chronic diseases by clinical pharmacists

Tao Xiaomei's Innovation Studio of Young Staff --A randomized controlled study of different pharmaceutical care models for patients with chronic diseases by clinical pharmacists

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069785
Enrollment
Unknown
Registered
2023-03-25
Start date
2023-03-16
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic disease

Interventions

MTMs+Routine diagnosis and treatment group:Medicine treatment management mode service
Routine diagnosis and treatment group :Routine diagnosis and treatment

Sponsors

Beijing Shijitan Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? At least one chronic disease (such as hypertension, type 2 diabetes, hyperlipidemia, coronary heart disease, chronic obstructive pneumonia, etc.); ? The number of long-term (continuous use of 28 days or more) combined use of chemicals = 3; ? It can provide laboratory examination indicators such as blood biochemistry and blood routine in the past two weeks, and has various main clinical examination results related to the chronic disease it suffers from; ? The patient voluntarily matched and signed the informed consent form.

Exclusion criteria

Exclusion criteria: ? Have a history of serious or uncontrolled neurological and psychiatric disorders; ? Those who have serious vision problems and are unable to read written information, have deafness, severe visual impairment, intellectual impairment, or have Alzheimer's disease; ? Life expectancy is less than 1 year; ? Have professional nursing personnel take care of their drug use; ? People who cannot use apps or phones to maintain stable contact; ? I have received MTM service in the past six months.

Design outcomes

Primary

MeasureTime frame
Reduction rate of irrational drug use;Unreasonable number of drug use per capita;

Secondary

MeasureTime frame
Compliance rate of clinical indicators;Incidence of adverse drug reactions;Prescription adjustment rate;Average monthly drug cost;Number of hospitalizations;Patient satisfaction;Implementation rate of pharmaceutical recommendations;Drug compliance score;

Countries

China

Contacts

Public ContactXiaomei Tao

Beijing Shijitan Hospital affiliated to Capital Medical University

taoxiaomei@bjsjth.cn+86 15110213722

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026